Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect recognition of the article's findings on gastrointestinal side effects, with several posts sharing personal experiences or questioning the broader implications, using tone and language that suggest genuine concern and curiosity. For example, one participant mentions that metformin causes diarrhea in 20-30% of patients, demonstrating direct engagement with the subject, while others question its use in treating Long Covid, indicating its impact on ongoing debates.
Most discussions acknowledge and support the findings of the publication, citing known side effects like gastrointestinal issues caused by metformin.
Participants show moderate curiosity, with some expressing surprise or skepticism about claims, indicating a sustained but cautious interest.
Comments include personal experiences, references to specific side effects, and discussion of the research methodology, showing active involvement.
The discussions highlight practical implications for treatment and skepticism, indicating the article's influence on perceptions and debates about diabetes management.
New Research: Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials: Introduction Metformin is the… https://t.co/OzOt4zbCXQ #Endocrinology #Endo
"Frontiers | Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials" @LHCH @LivHPartners @LJMU_Health : https://t.co/zXZ1kal9Q9 https://t.co/CzkhtiO4OF
@jamesrx1 @roxy_mojo Well I know for a fact it causes diarrhea and GI issues in 20-30% of patients. It is insane to me people are claiming it is a Long Covid Treatment. https://t.co/ieArB8Unw0
@nankooochan 追加で見ていても、今は 用量依存的に有害事象が増えるは否定的なものが多い気がしました。 これも、2500mg/dでは消化器系の有害事象が多かったけど、それ以下では変わりない。 1. https://t.co/4cXyiCK176 その他2つも同様 2. https://t.co/Zaf1TGntym 3. https://t.co/IfrfB9bWPt
Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies https://t.co/gUfb8Q8JhV https://t.co/qEJpeXYJbN
RT @FrontEndocrinol: New Research: Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A syst…
Discover the lesser-known benefits of Metformin, including its impact on BMI reduction, especially in high-BMI individuals, and its potential role in metabolic health, as supported by recent research.
If you've been prescribed metformin, it's important to know that gastrointestinal issues like diarrhea, gases, nausea, and abdominal pain occur in about 20-30% of patients. These symptoms depend on the dose and usually…
@nankooochan 追加で見ていても、今は 用量依存的に有害事象が増えるは否定的なものが多い気がしました。 これも、2500mg/dでは消化器系の有害事象が多かったけど、それ以下では変わりない。 1. https://t.co/4cXyiCK176 その他2つも同様 2. https://t.co/Zaf1TGntym 3. https://t.co/IfrfB9bWPt
Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies https://t.co/gUfb8Q8JhV https://t.co/qEJpeXYJbN
@jamesrx1 @roxy_mojo Well I know for a fact it causes diarrhea and GI issues in 20-30% of patients. It is insane to me people are claiming it is a Long Covid Treatment. https://t.co/ieArB8Unw0
RT @FrontEndocrinol: New Research: Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A syst…
New Research: Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials: Introduction Metformin is the… https://t.co/OzOt4zbCXQ #Endocrinology #Endo
"Frontiers | Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials" @LHCH @LivHPartners @LJMU_Health : https://t.co/zXZ1kal9Q9 https://t.co/CzkhtiO4OF
FE
LS
L
T北
CC